Literature DB >> 1715160

Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig hearts.

G Stark1, U Stark, M Windisch, M Vicenzi, U Eggenreich, S Nagl, K Kral, E Pilger, H A Tritthart.   

Abstract

During long-term treatment with amiodarone, slowing of conduction through the atrioventricular node, a prolongation of the QT-interval, and a prolongation of the atrial and ventricular myocardial refractoriness always developed. During short-term treatment, these effects were not found, except for depression of the AV-nodal conduction. This led to the suggestion that the electrophysiological effects of amiodarone during long-term treatment might be partly the result of the accumulation of its metabolite desethylamiodarone. Therefore, we examined the electrophysiological effects of amiodarone and desethylamiodarone on conduction and refractoriness in isolated spontaneously beating guinea pig hearts perfused by the method of Langendorff. Within 1 h of perfusion, desethylamiodarone caused a more pronounced prolongation of the AV-nodal, His-bundle, and intraventricular conduction intervals than did amiodarone. Desethylamiodarone, but not amiodarone led to a prolongation of the QT-interval. The refractoriness of sinoatrial-, AV-nodal conduction, and of the atrial myocardium were significantly more prolonged by amiodarone than by desethylamiodarone. Both compounds showed a comparable strong rate-dependent effect on AV-nodal refractoriness. The ventricular refractoriness was similarily prolonged by either compound. These results show that for the class-III effects (i.e., prolongation of repolarization period) observed under chronic treatment of amiodarone the metabolite desethylamiodarone may be responsible. Desethylamiodarone also exerts more pronounced effects on the fast-channel-dependent parts of the conduction system than does amiodarone, a fact indicated by a higher prolongation of His-bundle and intraventricular conduction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715160     DOI: 10.1007/bf02190546

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  28 in total

1.  Detection and continuous monitoring of intracardiac low-level potentials from the surface of the Langendorff-perfused heart.

Authors:  E Hofer; U Stark; G Stark; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

2.  Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers.

Authors:  A Varro; Y Nakaya; V Elharrar; B Surawicz
Journal:  Eur J Pharmacol       Date:  1985-06-19       Impact factor: 4.432

3.  Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite.

Authors:  M Talajic; M R DeRoode; S Nattel
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

4.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

Authors:  J W Mason; L M Hondeghem; B G Katzung
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

5.  Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.

Authors:  J J Heger; E N Prystowsky; D P Zipes
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

6.  Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region.

Authors:  H O Gloor; F Urthaler; T N James
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

7.  Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.

Authors:  B McGovern; H Garan; R F Malacoff; J P DiMarco; G Grant; T D Sellers; J N Ruskin
Journal:  Am J Cardiol       Date:  1984-06-01       Impact factor: 2.778

8.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  Amiodarone-induced ventricular fibrillation.

Authors:  J M McComb; K R Logan; M M Khan; J S Geddes; A A Adgey
Journal:  Eur J Cardiol       Date:  1980

10.  Modulation of cardiac impulse generation and conduction by nifedipine and verapamil analyzed by a refined surface ECG technique in Langendorff perfused guinea pig hearts.

Authors:  G Stark; U Stark; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1988 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.